| RS2492671663 |
PTF1A
|
Health Risk |
Pathogenic |
Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome, Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome |
| RS2492677971 |
LDB3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 4, Myofibrillar myopathy 4 |
| RS2492679787 |
COX15
|
Health Risk |
Likely pathogenic |
Cardioencephalomyopathy, fatal infantile |
| RS2492694754 |
FRA10AC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with growth retardation, dysmorphic facies |
| RS2492707413 |
COX15
|
Health Risk |
Pathogenic |
— |
| RS2492707758 |
COX15
|
Health Risk |
Pathogenic |
— |
| RS2492707791 |
COX15
|
Health Risk |
Likely pathogenic |
— |
| RS2492721228 |
COX15
|
Health Risk |
Pathogenic |
— |
| RS2492722405 |
COX15
|
Health Risk |
Pathogenic |
— |
| RS2492722994 |
COX15
|
Health Risk |
Pathogenic |
— |
| RS2492726078 |
COX15
|
Health Risk |
Pathogenic |
— |
| RS2492726663 |
COX15
|
Health Risk |
Pathogenic |
— |
| RS2492731216 |
C10orf67
|
Health Risk |
Pathogenic |
Pancreatic agenesis 2, Pancreatic agenesis 2 |
| RS2492731708 |
COX15
|
Health Risk |
Likely pathogenic |
— |
| RS2492734911 |
COX15
|
Health Risk |
Pathogenic |
— |
| RS2492740075 |
TCTN3
|
Health Risk |
Pathogenic |
Orofacial-digital syndrome IV, Joubert syndrome 18 |
| RS2492743120 |
TCTN3
|
Health Risk |
Pathogenic |
Orofacial-digital syndrome IV, Joubert syndrome 18 |
| RS2492746592 |
COX15
|
Health Risk |
Likely pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2492747662 |
COX15
|
Health Risk |
Pathogenic |
— |
| RS2492748621 |
TCTN3
|
Health Risk |
Pathogenic |
Joubert syndrome 18, Orofacial-digital syndrome IV |
| RS2492752964 |
TCTN3
|
Health Risk |
Likely pathogenic |
Joubert syndrome 18, Joubert syndrome 18 |
| RS2492753291 |
TCTN3
|
Health Risk |
Pathogenic |
Orofacial-digital syndrome IV, Joubert syndrome 18 |
| RS2492759374 |
SGPL1
|
Health Risk |
Pathogenic |
— |
| RS2492760878 |
TCTN3
|
Health Risk |
Pathogenic |
Joubert syndrome 18, Orofacial-digital syndrome IV |
| RS2492761413 |
TCTN3
|
Health Risk |
Pathogenic |
Joubert syndrome 18, Orofacial-digital syndrome IV |
| RS2492761440 |
TCTN3
|
Health Risk |
Likely pathogenic |
Joubert syndrome 18, Orofacial-digital syndrome IV |
| RS2492762089 |
LDB3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 4, Myofibrillar myopathy 4 |
| RS2492765537 |
SGPL1
|
Health Risk |
Pathogenic |
Nephrotic syndrome 14, Nephrotic syndrome 14 |
| RS2492770867 |
PDZD7
|
Health Risk |
Pathogenic |
— |
| RS2492777227 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 4, Cardiovascular phenotype |
| RS2492777637 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myofibrillar myopathy 4 |
| RS2492780008 |
SUFU
|
Health Risk |
Pathogenic/Likely pathogenic |
Gorlin syndrome, Basal cell nevus syndrome 2 |
| RS2492780262 |
SUFU
|
Health Risk |
Likely pathogenic |
Familial meningioma, Familial meningioma |
| RS2492780272 |
SUFU
|
Health Risk |
Likely pathogenic |
Medulloblastoma, Gorlin syndrome |
| RS2492782810 |
PDZD7
|
Health Risk |
Pathogenic/Likely pathogenic |
Deafness, Deafness |
| RS2492782878 |
PDZD7
|
Health Risk |
Pathogenic |
Usher syndrome, type IIC |
| RS2492784051 |
PDZD7
|
Health Risk |
Pathogenic |
— |
| RS2492784558 |
PDZD7
|
Health Risk |
Pathogenic |
— |
| RS2492789659 |
SUFU
|
Health Risk |
Pathogenic |
Gorlin syndrome, Medulloblastoma |
| RS2492790282 |
TCTN3
|
Health Risk |
Pathogenic |
Joubert syndrome 18, Orofacial-digital syndrome IV |
| RS2492790302 |
SUFU
|
Health Risk |
Pathogenic |
Gorlin syndrome, Medulloblastoma |
| RS2492790396 |
SUFU
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2492795223 |
PDZD7
|
Health Risk |
Pathogenic |
— |
| RS2492796553 |
LRMDA
|
Health Risk |
Likely pathogenic |
— |
| RS2492798769 |
SGPL1
|
Health Risk |
Likely pathogenic |
— |
| RS2492801872 |
LGI1
|
Health Risk |
Likely pathogenic |
Epilepsy, familial temporal lobe |
| RS2492804665 |
SGPL1
|
Health Risk |
Pathogenic |
— |
| RS2492804842 |
SGPL1
|
Health Risk |
Pathogenic |
Nephrotic syndrome 14, Nephrotic syndrome 14 |
| RS2492808478 |
LDB3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 4, Myofibrillar myopathy 4 |
| RS2492811004 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myofibrillar myopathy 4 |
| RS2492811707 |
SIGMAR1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 16, Autosomal recessive distal spinal muscular atrophy 2 |
| RS2492813518 |
SGPL1
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome 14, Nephrotic syndrome 14 |
| RS2492813605 |
ABCC2
|
Health Risk |
Pathogenic |
— |
| RS2492821542 |
PDZD7
|
Health Risk |
Likely pathogenic |
— |
| RS2492822470 |
CDH23
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome |
| RS2492822533 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2492822585 |
PDZD7
|
Health Risk |
Pathogenic |
— |
| RS2492823196 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2492825486 |
PAPSS2
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia, PAPSS2 type |
| RS2492828821 |
SIGMAR1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 16, Autosomal recessive distal spinal muscular atrophy 2 |
| RS2492830006 |
PCBD1
|
Health Risk |
Likely pathogenic |
Pterin-4 alpha-carbinolamine dehydratase 1 deficiency, Pterin-4 alpha-carbinolamine dehydratase 1 deficiency |
| RS2492831158 |
DNAJC12
|
Health Risk |
Pathogenic |
— |
| RS2492832243 |
PCBD1
|
Health Risk |
Pathogenic |
Pterin-4 alpha-carbinolamine dehydratase 1 deficiency, Pterin-4 alpha-carbinolamine dehydratase 1 deficiency |
| RS2492833589 |
PCBD1
|
Health Risk |
Likely pathogenic |
Pterin-4 alpha-carbinolamine dehydratase 1 deficiency, Pterin-4 alpha-carbinolamine dehydratase 1 deficiency |
| RS2492833598 |
PCBD1
|
Health Risk |
Pathogenic |
Pterin-4 alpha-carbinolamine dehydratase 1 deficiency, Pterin-4 alpha-carbinolamine dehydratase 1 deficiency |
| RS2492840455 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2492840553 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2492841066 |
BLNK
|
Health Risk |
Likely pathogenic |
Agammaglobulinemia 4, autosomal recessive |
| RS2492841473 |
ABCC2
|
Health Risk |
Likely pathogenic |
— |
| RS2492841988 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2492842718 |
ABCC2
|
Health Risk |
Pathogenic |
— |
| RS2492843112 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2492843419 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2492843561 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2492843794 |
ABCC2
|
Health Risk |
Likely pathogenic |
— |
| RS2492846692 |
ABCC2
|
Health Risk |
Pathogenic |
— |
| RS2492846710 |
ABCC2
|
Health Risk |
Likely pathogenic |
— |
| RS2492847060 |
PAPSS2
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia, PAPSS2 type |
| RS2492858015 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS2492858066 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS2492858501 |
GALT
|
Health Risk |
Pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS2492859908 |
ABCC2
|
Health Risk |
Pathogenic |
— |
| RS2492860078 |
ABCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Dubin-Johnson syndrome, Dubin-Johnson syndrome |
| RS2492860700 |
LGI1
|
Health Risk |
Pathogenic |
Autosomal dominant epilepsy with auditory features, Autosomal dominant epilepsy with auditory features |
| RS2492861648 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS2492861889 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS2492861943 |
GALT
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS2492862330 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS2492862390 |
GALT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS2492862494 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS2492862629 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS2492863993 |
GALT
|
Health Risk |
Pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS2492863998 |
GALT
|
Health Risk |
Pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS2492864348 |
GALT
|
Health Risk |
Likely pathogenic |
GALT-related disorder, GALT-related disorder |
| RS2492865820 |
GALT
|
Health Risk |
Pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Galactosemia |
| RS2492866246 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS2492866563 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS2492866691 |
GALT
|
Health Risk |
Pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS2492866721 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS2492867642 |
ABCC2
|
Health Risk |
Pathogenic |
— |